For investors who can tolerate high risk I am
recommending biotech stocks Northwest Biotherapeutics (NWBO) and TG Therapeutics (TGTX). Both companies are developing cancer
treatments that are showing very promising efficacy with excellent safety profiles. Both
these stocks have an enormous market potential while their current share prices are beaten down in
value. With clinical successes in 2017 & 2018 both these stocks have potential to become multi-baggers.
